The controversy over Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics’ recalled metal-on-metal hip implants hit courts in Ireland for the 1st time this week.
Metal-on-Metal
Growing metal-on-metal hip controversy threatens to swallow more device makers
As the legal fallout over metal-on-metal hip implants continue to grow, the controversy threatens to swallow all MoM device makers, even those that have avoided a recall so far.
Bellwether trials of DePuy’s New Jersey hip lawsuit set for late next year
A pair of bellwether trials against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics’ metal-on-metal hip implants are set take place next year, setting the framework for the ongoing litigation in New Jersey.
Biomet M2A Magnum hip implant lawsuits consolidated in Indiana
A raft of personal injury lawsuits filed over Biomet‘s M2A Magnum metal-on-metal hip implant have been consolidated in a federal court in Indiana.
The U.S. Judicial Panel on Multidistrict Litigation moved 65 pending cases from other jurisdictions to the U.S. District Court for Northern Indiana, over Biomet’s objections.
Hips: Smith & Nephew issues failure warning on Birmingham metal-on-metal hips
Updated September 25, 2012, at 5:45 p.m. with comment from Smith & Nephew.
Metal-on-metal hip implant study finds no cancer link at 7 years
Plaintiffs look to depose new Johnson & Johnson CEO Gorsky in DePuy ASR lawsuit
The plaintiffs in a personal injury lawsuit filed over Johnson & Johnson‘s (NYSE:JNJ) recalled DePuy ASR hip implant want the healthcare conglomerate’s new top dog to testify.
The plaintiffs, led by Moira Jackson, sued over the metal-on-metal hip implant, which was pulled off the market in August 2010, after research showed abnormally high rates of revision surgeries.
DePuy execs to testify in hip implant recall trials
Eight former and current executives from Johnson & Johnson‘s (NYSE:JNJ) DePuy Orthopaedics subsidiary are being called to testify in the multi-district litigation over the recalled DePuy ASR metal-on-metal hip implant.
Hip lawsuit update: Judge orders J&J and litigants to work together
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics must work together with plaintiffs who are suing the company over allegedly faulty hip implants, ordered U.S. District Judge Ed Kinkeade.
Will a 2-year statute of limitations defense curb J&J’s DePuy hip lawsuits?
Patients may be out of time to file lawsuits against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics’ recalled metal-on-metal hip implants, with the 2-year anniversary of the recall passing over the weekend.
First DePuy ASR lawsuit settles before trial
The 1st lawsuit in what’s likely to be a long series filed against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics over its ASR metal-on-metal hip implant settled ahead of trial, according to court documents.
The case, Rundle et al vs. DePuy Orthopaedics, was slated to go before a jury Dec. 3 in Nevada’s 8th Judicial District Court.